Limmatstrasse 264
CH – 8005 Zurich
Switzerland
Will they/Won’t they? The Jackson Hole meeting at the end of August and the question around slowing the pace of bond purchases spooked the market throughout the whole month (next to the Delta-variant). In such times of uncertainties Healthcare (2.8%) did what it is supposed to do: it outperformed the market (2.5%). Year to date, Healthcare (17.2%) trades now almost on par with the global markets (17.9%)
Detecting cancer early on can make such a big difference. The good news is that cancer screening will get much easier in the future.
February was a month of twists and turns for the healthcare industry! From the ebb and flow of macro dynamics to the ups and downs of the Q4 reporting season, healthcare stocks experienced a flurry of activity. Meanwhile, the Medtech, Pharma, and Providers space saw a surge of M&A activity. More in this month’s commentary.
Did you know that every 34 seconds a person dies in the United States from cardiovascular disease? It’s the leading cause not only in the US, but also globally.
Get in contact with us by using the form below or via telephone. We look forward to hearing from you.
Lorem ipsum dolor sit amet, consectetuer adipiscing elit. Aenean commodo ligula eget dolor. Aenean massa. Cum sociis natoque penatibus et magnis dis parturient montes, nascetur ridiculus mus. Donec quam felis, ultricies nec, pellentesque eu, pretium quis, sem.
There are no job vacancies at the moment.